Few Doctors Would Consider Euthanasia in Psychiatric Disease

This article originally appeared here.
Share this content:
Few Doctors Would Consider Euthanasia in Psychiatric Disease
Few Doctors Would Consider Euthanasia in Psychiatric Disease

WEDNESDAY, Feb. 18, 2015 (HealthDay News) -- Few physicians would find euthanasia and physician-assisted suicide (EAS) conceivable for patients with psychiatric disease, dementia, or those who are "tired of living," according to a study from the Netherlands published online Feb. 18 in the Journal of Medical Ethics.

Eva Elizabeth Bolt, from the VU University Medical Center in Amsterdam, and colleagues examined whether physicians can conceive of granting requests for EAS in patients with cancer, another physical disease, psychiatric disease, dementia, or among those who are tired of living. Data were collected from a cross-sectional survey conducted among 2,269 Dutch general practitioners, elderly care physicians, and clinical specialists (response rate, 64 percent).

The researchers found that most physicians reported that it was conceivable that they would grant an EAS request for a patient with cancer (85 percent) or another physical disease (82 percent). A minority of physicians found it conceivable that they would grant this request in patients with psychiatric disease (34 percent), early-stage dementia (40 percent), advanced dementia (29 to 33 percent), or for those who were tired of living (27 percent). The likelihood of finding it conceivable that they would perform EAS was highest for general practitioners.

"This study shows that a minority of Dutch physicians find it conceivable that they would grant a request for EAS from a patient with psychiatric disease, dementia, or a patient who is tired of living," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »